TRANSCAN 2: pubblicato il nuovo bando dedicato alla ricerca sul cancro

La Commissione europea ha recentemente deciso di continuare a finanziare TRANSCAN, l'ERA-NET europea dedicata alla ricerca sul cancro. L'obbiettivo di TRANSCAN (Translational Cancer Research) è quello di coordinare i programmi di finanziamento regionali e nazionali dedicati alla ricerca sul cancro, promuovendo un approccio collaborativo transnazionale.

A tal fine, il nuovo consorzio ha annunciato la pubblicazione del nuovo bando internazionale (JTC 2016) dedicato al topic "Minimally and non-invasive methods for early detection and/or progression of cancer". Il topic viene declinato su tre diverse finalità:

• Aim 1: Risk stratification to distinguish groups by susceptibility for development or progression of cancer based on molecular biomarkers and established cancer risk factors, such as age, medical history, anthropometrics (e.g., body mass index, waist circumference), and lifestyle related determinants (e.g., diet, physical exercise, environmental exposure and medication)
• Aim 2: Validation of multiparametric methods, using the combination of promising(*) biomarkers (genomic, proteomic, metabolomic and imaging markers) to improve our capability for early detection or progression of cancer
• Aim 3: Improve clinical evidence of the minimally invasive methods

Le seguenti organizzazioni finanzieranno la call:

• Research Foundation - Flanders (FWO), Belgium, Flanders
• Fund for Scientific Research (FNRS), Belgium, French speaking community
• Estonian Research Council (ETAg), Estonia
• National Cancer Institute (INCa), France
• ARC French Foundation for Cancer Research (ARC Foundation), France
• Federal Ministry of Education and Research (BMBF), Germany
• General Secretariat for Research and Technology (GSRT), Greece
• The Chief Scientist Office of the Ministry of Health (CSO-MOH), Israel
• Ministry of Health (MoH), Italy
• Alliance Against Cancer (ACC), Italy
• Lombardy Foundation for Biomedical Research (FRRB), Italy
• State Education Development Agency (VIAA), Latvia
• Dutch Cancer Society (DCS), Netherlands
• Research Council of Norway (RCN), Norway
• Norwegian Cancer Society (NSC), Norway
• National Centre for Research and Development (NCBR), Poland
• Slovak Academy of Sciences (SAS), Slovakia
• Ministry of Education, Science and Sports (MIZS), Slovenia
• Spanish Association Against Cancer Scientific Foundation (AECC FC), Spain
• National Institute of Health Carlos III (ISCIII), Spain
• The Foundation for the Support of the Applied Scientific Research and Technology in Asturias (FICYT), Spain
• Ministry of Science and Technology (MoST), Taiwan
• Scientific and Technological Research Council (TUBITAK), Turkey

Per quanto riguarda l'Italia, di seguito il budget e il numero massimo di progetti che le singole organizzazzioni intendo finanziare:

• Ministry of Health (MoH): 3.000.000€ - 10 progetti
• Alliance Against Cancer (ACC): 250.000€ - 1/2 progetti
• Lombardy Foundation for Biomedical Research (FRRB): 1.000.000€ - 2 progetti

Maggiori informazioni sui topic e sulle regole di partecipazione sono pubblicate nel testo del bando e nella guida per i partecipanti.